0001566028-13-000032.txt : 20131010 0001566028-13-000032.hdr.sgml : 20131010 20131010165222 ACCESSION NUMBER: 0001566028-13-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131008 FILED AS OF DATE: 20131010 DATE AS OF CHANGE: 20131010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SELTZER DAVID S CENTRAL INDEX KEY: 0001054694 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20424 FILM NUMBER: 131146368 MAIL ADDRESS: STREET 1: C/O TASHLIK KREUTZER & GOLDWYN PC STREET 2: 833 NORTHERN BLVD CITY: GREAT NECK STATE: NY ZIP: 11021 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-10-08 0000887497 HI TECH PHARMACAL CO INC HITK 0001054694 SELTZER DAVID S C/O HI-TECH PHARMACAL CO., INC. 369 BAYVIEW AVENUE AMITYVILLE NY 11701 1 1 1 0 CEO, President, Sec'y, Treas. Common Stock 2013-10-08 4 S 0 23000 43.09 D 1290703 D Common Stock 2013-10-09 4 F 0 26091 43.09 D 1264612 D Common Stock 2013-10-09 4 M 0 75000 14.99 A 1339612 D Common Stock 167445 I By Spouse and Issue Common Stock 57482 I As Trustee of Trust for the Benefit of his Child Stock Option (Right to Buy) 14.99 2013-10-09 4 M 0 75000 0 D 2004-12-04 2013-12-04 Common Stock 75000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.06 to $43.12, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan The option became exercisable in four (4) equal installments beginning on the first anniversary of the grant date. Other than the option reflected on this form, Mr. Seltzer is also the holder of additional options to acquire an aggregate of 475,000 additional shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices, exercise dates and expiration dates. David S. Seltzer 2013-10-10